New study tests virtual coaching to improve life after cancer treatment
NCT ID NCT04428905
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase III trial is testing whether a telehealth self-management program can improve care coordination and quality of life for survivors of non-small cell lung cancer or colorectal cancer. About 403 participants who finished treatment 4 months ago will receive coaching sessions, a personalized care plan, and resources. The study compares their outcomes to those receiving standard attention, measuring communication with doctors and confidence in survivorship care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- telehealth self-management program
- What this could lead to
- If successful, this program could help cancer survivors feel more confident about follow-up care and improve communication with their doctors.
- What could go wrong
- This is a behavioral intervention, not a new drug or cure. Results depend on patient engagement and may not apply to all survivors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 3
Large-scale testing in a bigger group. Usually the last step before a treatment can be approved.
- Participants
-
403 people
The number who actually took part.
- Started
-
Jul 2020
- Expected to finish
-
Mar 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Non-small cell lung cancer (NSCLC) and colorectal cancer survivors who are 4 months post-treatment completion * History of stage I-III disease * Ability to read or understand English * All subjects must have the ability to understand and the willingness to sign a written informed consent Exclusion Criteria: * Subjects, who in the opinion of the principal investigator (PI), may not be able to comply with the requirements of the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Lung non-small cell carcinoma are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
City of Hope Medical Center
Duarte, California, 91010, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a vaccine stop GI cancers from returning?
- Can a new blood test spot colorectal cancer return earlier?
- Facing the fear: a new program aims to ease anxiety in advanced cancer
- Radiation hotspots may boost lung cancer treatment — a trial puts it to the test
- Experimental drug combo targets Hard-to-Treat GI cancers
- Could a simple assessment help older lung cancer patients tolerate chemo better?